Cargando…
Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95
Synthetic biology has emerged as a useful technology for studying cytokine signal transduction. Recently, we described fully synthetic cytokine receptors to phenocopy trimeric receptors such as the death receptor Fas/CD95. Using a nanobody as an extracellular-binding domain for mCherry fused to the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413154/ https://www.ncbi.nlm.nih.gov/pubmed/37392849 http://dx.doi.org/10.1016/j.jbc.2023.104989 |
_version_ | 1785087074754363392 |
---|---|
author | Minafra, Anna Rita Rafii, Puyan Mossner, Sofie Bazgir, Farhad Floss, Doreen M. Moll, Jens M. Scheller, Jürgen |
author_facet | Minafra, Anna Rita Rafii, Puyan Mossner, Sofie Bazgir, Farhad Floss, Doreen M. Moll, Jens M. Scheller, Jürgen |
author_sort | Minafra, Anna Rita |
collection | PubMed |
description | Synthetic biology has emerged as a useful technology for studying cytokine signal transduction. Recently, we described fully synthetic cytokine receptors to phenocopy trimeric receptors such as the death receptor Fas/CD95. Using a nanobody as an extracellular-binding domain for mCherry fused to the natural receptor’s transmembrane and intracellular domain, trimeric mCherry ligands were able to induce cell death. Among the 17,889 single nucleotide variants in the SNP database for Fas, 337 represent missense mutations that functionally remained largely uncharacterized. Here, we developed a workflow for the Fas synthetic cytokine receptor system to functionally characterize missense SNPs within the transmembrane and intracellular domain of Fas. To validate our system, we selected five functionally assigned loss-of-function (LOF) polymorphisms and included 15 additional unassigned SNPs. Moreover, based on structural data, 15 gain-of-function or LOF candidate mutations were additionally selected. All 35 nucleotide variants were functionally investigated through cellular proliferation, apoptosis and caspases 3 and 7 cleavage assays. Collectively, our results showed that 30 variants resulted in partial or complete LOF, while five lead to a gain-of-function. In conclusion, we demonstrated that synthetic cytokine receptors are a suitable tool for functional SNPs/mutations characterization in a structured workflow. |
format | Online Article Text |
id | pubmed-10413154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-104131542023-08-11 Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95 Minafra, Anna Rita Rafii, Puyan Mossner, Sofie Bazgir, Farhad Floss, Doreen M. Moll, Jens M. Scheller, Jürgen J Biol Chem Research Article Synthetic biology has emerged as a useful technology for studying cytokine signal transduction. Recently, we described fully synthetic cytokine receptors to phenocopy trimeric receptors such as the death receptor Fas/CD95. Using a nanobody as an extracellular-binding domain for mCherry fused to the natural receptor’s transmembrane and intracellular domain, trimeric mCherry ligands were able to induce cell death. Among the 17,889 single nucleotide variants in the SNP database for Fas, 337 represent missense mutations that functionally remained largely uncharacterized. Here, we developed a workflow for the Fas synthetic cytokine receptor system to functionally characterize missense SNPs within the transmembrane and intracellular domain of Fas. To validate our system, we selected five functionally assigned loss-of-function (LOF) polymorphisms and included 15 additional unassigned SNPs. Moreover, based on structural data, 15 gain-of-function or LOF candidate mutations were additionally selected. All 35 nucleotide variants were functionally investigated through cellular proliferation, apoptosis and caspases 3 and 7 cleavage assays. Collectively, our results showed that 30 variants resulted in partial or complete LOF, while five lead to a gain-of-function. In conclusion, we demonstrated that synthetic cytokine receptors are a suitable tool for functional SNPs/mutations characterization in a structured workflow. American Society for Biochemistry and Molecular Biology 2023-06-29 /pmc/articles/PMC10413154/ /pubmed/37392849 http://dx.doi.org/10.1016/j.jbc.2023.104989 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Minafra, Anna Rita Rafii, Puyan Mossner, Sofie Bazgir, Farhad Floss, Doreen M. Moll, Jens M. Scheller, Jürgen Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95 |
title | Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95 |
title_full | Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95 |
title_fullStr | Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95 |
title_full_unstemmed | Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95 |
title_short | Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95 |
title_sort | synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor fas/cd95 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413154/ https://www.ncbi.nlm.nih.gov/pubmed/37392849 http://dx.doi.org/10.1016/j.jbc.2023.104989 |
work_keys_str_mv | AT minafraannarita syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95 AT rafiipuyan syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95 AT mossnersofie syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95 AT bazgirfarhad syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95 AT flossdoreenm syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95 AT molljensm syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95 AT schellerjurgen syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95 |